| Same FDA Requirements
|
| |
Brand-Name Drug |
Generic Drug |
For reformulations of a brand-name drug or generic versions of a drug, the FDA
reviews data showing the drug is bioequivalent to the one used in the original
safety and efficacy testing.
|
 |
|
FDA evaluates the manufacturer's adherence to good manufacturing practices
before the drug is marketed.
|
|
|
FDA reviews the active and inactive ingredients used in the formulation before
the drug is marketed.
|
|
|
FDA reviews the actual drug product.
|
|
|
FDA reviews the drug's labeling.
|
|
|
Manufacturer must seek FDA approval before making major manufacturing changes
or reformulating the drug.
|
|
|
Manufacturer must report adverse reactions and serious adverse health effects
to the FDA.
|
|
|
FDA periodically inspects manufacturing plants.
|
|
|
FDA monitors drug quality after approval.
|
|
|